Health care stocks were lower Monday afternoon, with the NYSE Health Care Index shedding 0.5% and the Health Care Select Sector SPDR Fund (XLV) down 0.1%.
The iShares Biotechnology ETF (IBB) retreated 0.1%.
In corporate news, Novo Nordisk (NVO) shares fell 9% after the latest trial results of the Danish drugmaker's investigative weight loss drug, CagriSema, trailed its own initial expectations.
Checkpoint Therapeutics (CKPT) shares were rising nearly 62% after the firm and India's Sun Pharmaceutical said Sunday that Checkpoint has agreed to be acquired by Sun for $4.10 a share in cash plus a non-transferable contingent value right.
BioNTech (BNTX) reported a decline in Q4 revenue and projected full-year sales to fall again in 2025. Its shares fell 2.6%.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。